– because cancer patients are individuals

News and Press Releases

2020-10-14

Press Releases Regulatory

Notice of extraordinary general meeting in 2cureX AB

The shareholders of 2cureX AB, reg. no. 559128-0077, (the “Company“) are hereby invited to the extra general meeting on Thursday...

2020-10-12

News

2cureX featured in Dansk Biotek’s overview of Danish biotech

You can view the article here (page 23) (Danish).

2020-10-01

Press Releases Regulatory

Last patient successfully enrolled in the world’s first interventional trial with 3D microtumors as guide for choice of cancer treatment.

According to schedule, 2cureX’s clinical partner University Hospital Vejle today enrolled the last patient in the clinical validation study TICC1....

To the news archive

Meet 2cureX

October 19-21, 2020

TechConnect EUROPE, Malmö, Sweden

Click here for more information

September 24, 2020

Biotech Atelier 2020, Bulgarian (Virtual)

Click here for more information

September 18, 2020

European Society of Medical Oncology, ESMO Congress 2020, Virtual

Click here for more information

Contact information

2cureX, Fruebjergvej 3, 2100 Copenhagen Ø, Denmark| Phone: +45 2211 5399| E-mail: info@2curex.com

Privacy Policy | Imprint